Rice Hall James & Associates LLC boosted its position in shares of Proto Labs Inc. (NYSE:PRLB) by 77.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 271,806 shares of the company’s stock after buying an additional 118,787 shares during the period. Rice Hall James & Associates LLC owned 1.03% of Proto Labs worth $15,645,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in PRLB. UBS Group AG boosted its position in shares of Proto Labs by 19.2% in the first quarter. UBS Group AG now owns 40,821 shares of the company’s stock worth $3,147,000 after buying an additional 6,568 shares during the period. State Street Corp boosted its position in shares of Proto Labs by 19.3% in the first quarter. State Street Corp now owns 442,097 shares of the company’s stock worth $34,079,000 after buying an additional 71,609 shares during the period. Cupps Capital Management LLC boosted its position in shares of Proto Labs by 30,531.6% in the first quarter. Cupps Capital Management LLC now owns 29,100 shares of the company’s stock worth $2,243,000 after buying an additional 29,005 shares during the period. Motley Fool Wealth Management LLC boosted its position in shares of Proto Labs by 10.6% in the first quarter. Motley Fool Wealth Management LLC now owns 42,174 shares of the company’s stock worth $3,251,000 after buying an additional 4,054 shares during the period. Finally, BlackRock Institutional Trust Company N.A. boosted its position in shares of Proto Labs by 0.5% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 583,668 shares of the company’s stock worth $44,995,000 after buying an additional 2,958 shares during the period.

Institutional Ownership by Quarter for Proto Labs (NYSE:PRLB)

Shares of Proto Labs Inc. (NYSE:PRLB) traded down 0.45% during midday trading on Tuesday, hitting $57.63. The stock had a trading volume of 360,960 shares. Proto Labs Inc. has a one year low of $50.50 and a one year high of $82.06. The stock has a 50 day moving average of $57.01 and a 200-day moving average of $63.08. The company has a market cap of $1.52 billion, a P/E ratio of 33.33 and a beta of 0.49.

Proto Labs (NYSE:PRLB) last released its earnings results on Thursday, July 28th. The company reported $0.45 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.48 by $0.03. The business earned $75 million during the quarter, compared to analyst estimates of $77.20 million. Proto Labs had a net margin of 15.82% and a return on equity of 13.76%. The business’s revenue for the quarter was up 17.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.50 earnings per share. Analysts forecast that Proto Labs Inc. will post $1.83 EPS for the current fiscal year.

A number of research firms have issued reports on PRLB. FBR & Co reaffirmed a “buy” rating on shares of Proto Labs in a research report on Monday, June 6th. Zacks Investment Research raised Proto Labs from a “hold” rating to a “buy” rating and set a $68.00 price target on the stock in a research report on Wednesday, July 13th. Dougherty & Co lowered Proto Labs from a “buy” rating to a “sell” rating in a research report on Wednesday, August 31st. TheStreet lowered Proto Labs from a “buy” rating to a “hold” rating in a research report on Wednesday, July 6th. Finally, Canaccord Genuity reaffirmed a “buy” rating and issued a $65.00 price target on shares of Proto Labs in a research report on Friday, September 2nd. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and two have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $70.40.

In other news, insider Arthur R. Baker III purchased 3,000 shares of the stock in a transaction on Thursday, September 1st. The stock was purchased at an average price of $55.00 per share, with a total value of $165,000.00. Following the completion of the transaction, the insider now owns 7,105 shares in the company, valued at $390,775. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 8.48% of the stock is owned by corporate insiders.

Proto Labs Company Profile

Proto Labs, Inc is an online and technology-enabled manufacturer of on-demand three-dimensional (3D)-printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. It utilizes injection molding, CNC machining and 3D printing to manufacture custom parts for its customers.

5 Day Chart for NYSE:PRLB

Receive News & Stock Ratings for Proto Labs Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs Inc. and related stocks with our FREE daily email newsletter.